VC  Synthesis Capital

http://www.synthesiscapital.com





     Office Locations:

184 High Street, 4th Floor
Boston, MA 02110
Phone: 857-366-8456
Fax: 857-366-8466

 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Synthesis Capital is a Boston-based firm led by a team of investment professionals who previously managed the healthcare venture practice within Advent International for over 14 years. Collectively, the Synthesis Capital Team has led or helped manage over 35 private equity and venture investments in biotechnology, medical device companies and healthcare services at all stages of development, with 28 achieving exit/liquidity events (14 IPOs and 14 Trade Sales). Synthesis focuses on investment opportunities in the biotechnology and medical technology sectors. Synthesis typically invests $10 million to $15 million per company with the ability to scale-up opportunistically on select investments. The firm prefers to invest in companies in the US or Europe with either breakthrough science or with highly compelling clinical data.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Charles Cohen PhD Co-Founder
    Jason Fisherman MD Co-Founder
    Tom Needham Co-Founder

     

    Portfolio companies include:

     

    Recent News:


      There is no recent news for Synthesis Capital.